Supachai Rerks‐Ngarm

12.0k citations

43 papers · 809 indexed · h-index 15

Virology top 1%
- HIV Research and Treatment 34
Infectious Diseases top 5%
- HIV/AIDS Research and Interventions 9
Immunology top 10%
- Immune Cell Function and Interaction 13
- T-cell and B-cell Immunology 8
Microbiology top 10%
Epidemiology
- Hepatitis B Virus Studies 4
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 8
Molecular Biology
- vaccines and immunoinformatics approaches 5
Health
- Vaccine Coverage and Hesitancy 4

Co-authors: Nelson L. Michael Jérôme H. Kim Punnee Pitisuttithum Sorachai Nitayaphan Jean‐Louis Excler Jaranit Kaewkungwal J Kreiss Nancy L. Young
Cited by: Virology Infectious Diseases Immunology
Journals: The Lancet (1 paper)Nature Communications (1 paper)SHILAP Revista de lepidopterología (1 paper)
Partner nations: Thailand United States South Korea

In The Last Decade

Supachai Rerks‐Ngarm

42 papers receiving 793 citations

Peers

Countries citing papers authored by Supachai Rerks‐Ngarm

Since Specialization

Citations

This map shows the geographic impact of Supachai Rerks‐Ngarm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Supachai Rerks‐Ngarm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Supachai Rerks‐Ngarm more than expected).

Fields of papers citing papers by Supachai Rerks‐Ngarm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Supachai Rerks‐Ngarm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Supachai Rerks‐Ngarm. The network helps show where Supachai Rerks‐Ngarm may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Supachai Rerks‐Ngarm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Supachai Rerks‐Ngarm Line = papers co-authored together Supachai Rerks‐Ngarm links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Prevalence of HPV infection among Thai schoolgirls in the north-eastern provinces in 2018: implications for HPV immunization policy IJID Regions ·Sompong Vongpunsawad,Chulwoo Rhee,Pornjarim Nilyanimit,Nimesh Poudyal,Suchada Jiamsiri,Hyeon Seon Ahn,Jinae Lee,Hyeong-Won Seo,Worrawan Klinsupa,Sunju Park,Nakorn Premsri,Chawetsan Namwat,Patummal Silaporn,Jean‐Louis Excler,Deok-Ryun Kim,Lauri E. Markowitz,Elizabeth R. Unger,Supachai Rerks‐Ngarm,Julia Lynch,Yong Poovorawan	2023	2
2	Protein-based, but not viral vector alone, HIV vaccine boosting drives an IgG1-biased polyfunctional humoral immune response JCI Insight ·Stephanie Fischinger,Sally Shin,Carolyn M. Boudreau,Margaret E. Ackerman,Supachai Rerks‐Ngarm,Punnee Pitisuttithum,Sorachai Nitayaphan,Jérôme H. Kim,Merlin L. Robb,Nelson L. Michael,Robert J. O’Connell,Sandhya Vasan,Hendrik Streeck,Galit Alter	2020	7
3	IgG3 collaborates with IgG1 and IgA to recruit effector function in RV144 vaccinees JCI Insight ·Stephanie Fischinger,Sepideh Dolatshahi,Madeleine F. Jennewein,Supachai Rerks‐Ngarm,Punnee Pitisuttithum,Sorachai Nitayaphan,Nelson L. Michael,Sandhya Vasan,Margaret E. Ackerman,Hendrik Streeck,Galit Alter	2020	12
4	Integrated systems approach defines the antiviral pathways conferring protection by the RV144 HIV vaccine Nature Communications ·Slim Fourati,Susan Pereira Ribeiro,Filipa Blasco Tavares Pereira Lopes,Aarthi Talla,François Lefebvre,Mark J. Cameron,Jaranit Kaewkungwal,Punnee Pitisuttithum,Sorachai Nitayaphan,Supachai Rerks‐Ngarm,Jérôme H. Kim,Rasmi Thomas,Peter B. Gilbert,Georgia D. Tomaras,Richard A. Koup,Nelson L. Michael,M. Juliana McElrath,Raphaël Gottardo,Rafick‐Pierre Sékaly	2019	24
5	Characterization of HIV-1 gp120 antibody specificities induced in anogenital secretions of RV144 vaccine recipients after late boost immunizations PLoS ONE ·Siriwat Akapirat,Chitraporn Karnasuta,Sandhya Vasan,Supachai Rerks‐Ngarm,Punnee Pitisuttithum,Sirinan Madnote,Hathairat Savadsuk,Surawach Rittiroongrad,Jiraporn Puangkaew,Sanjay Phogat,James Tartaglia,Faruk Sinangil,Mark de Souza,Jean‐Louis Excler,Jérôme H. Kim,Merlin L. Robb,Nelson L. Michael,Viseth Ngauy,Robert J. O’Connell,Nicos Karasavvas,(unknown)	2018	11
6	A novel mechanism linking memory stem cells with innate immunity in protection against HIV-1 infection Scientific Reports ·Yufei Wang,Trevor Whittall,Stuart J. D. Neil,Gary Britton,Mukesh Mistry,Supachai Rerks‐Ngarm,Punnee Pitisuttithum,Jaranit Kaewkungwal,Sorachai Nitayaphan,Xuesong Yu,Alicia Sato,Robert J. O’Connell,Nelson L. Michael,Merlin L. Robb,Jérôme H. Kim,Thomas Lehner	2017	6
7	Comparison of Antibody Responses Induced by RV144, VAX003, and VAX004 Vaccination Regimens AIDS Research and Human Retroviruses ·Chitraporn Karnasuta,Siriwat Akapirat,Sirinan Madnote,Hathairat Savadsuk,Jiraporn Puangkaew,Surawach Rittiroongrad,Supachai Rerks‐Ngarm,Sorachai Nitayaphan,Punnee Pitisuttithum,Jaranit Kaewkungwal,James Tartaglia,Faruk Sinangil,Donald P. Francis,Merlin L. Robb,Mark de Souza,Nelson L. Michael,Jean‐Louis Excler,Jérôme H. Kim,Robert J. O’Connell,Nicos Karasavvas	2016	27
8	Machine Learning Methods Enable Predictive Modeling of Antibody Feature:Function Relationships in RV144 Vaccinees PLoS Computational Biology ·Ickwon Choi,Amy W. Chung,Todd J. Suscovich,Supachai Rerks‐Ngarm,Punnee Pitisuttithum,Sorachai Nitayaphan,Jaranit Kaewkungwal,Robert J. O’Connell,Donald P. Francis,Merlin L. Robb,Nelson L. Michael,Jérôme H. Kim,Galit Alter,Margaret E. Ackerman,Chris Bailey‐Kellogg	2015	32
9	Accuracy of Clinical Diagnosis of Dengue Episodes in the RV144 HIV Vaccine Efficacy Trial in Thailand PLoS ONE ·Punnee Pitisuttithum,Supachai Rerks‐Ngarm,Donald M. Stablein,Peter Dawson,Sorachai Nitayaphan,Jaranit Kaewkungwal,Nelson L. Michael,Jérôme H. Kim,Merlin L. Robb,Robert J. O’Connell,In‐Kyu Yoon,Stefan Fernandez,Jean‐Louis Excler	2015	2
10	Sex Differences in Immune Variables in the RV144 Trial AIDS Research and Human Retroviruses ·Darpun Sachdev,Hasan Ahmed,Yunda Huang,Peter B. Gilbert,Supachai Rerks‐Ngarm,Jaranit Kaewkungwal,Sorachai Nitayaphan,Nelson Michael,Punnee Pitisuttithum,Merlin L. Robb,Jérôme H. Kim,Robert J. O’Connell,Nicole Frahm,Cecilia Morgan,Susan Buchbinder	2014	1
11	Aggregate complexes of HIV-1 induced by multimeric antibodies Retrovirology ·Daniel J Stieh,Deborah King,Katja Klein,Pinghuang Liu,Xiaoying Shen,Kwan Ki Hwang,Guido Ferrari,David C. Montefiori,Barton F. Haynes,Punnee Pitisuttithum,Jaranit Kaewkungwal,Sorachai Nitayaphan,Supachai Rerks‐Ngarm,Nelson L. Michael,Merlin L. Robb,Jérôme H. Kim,Thomas N. Denny,Georgia D. Tomaras,Robin J. Shattock	2014	24
12	Evaluation of Mucosal Tissue Explants as Ex Vivo Surrogates of In Vivo Vaccination of Non-human Primates (NHPs) and Humans AIDS Research and Human Retroviruses ·Carolina Herrera,Ronald S. Veazey,Alexandra Schuetz,Natalia Olejniczak,Agnès-Laurence Chenine,Sorachai Nitayaphan,Jaranit Kaewkungwal,Punnee Pitisuttithum,Supachai Rerks‐Ngarm,Robert J. O’Connell,Jean‐Louis Excler,Jérôme H. Kim,Robin J. Shattock	2014	1
13	HIV-specific Antibody in Rectal Secretions Following Late Boosts in RV144 Participants (RV305) AIDS Research and Human Retroviruses ·Siriwat Akapirat,Chitraporn Karnasuta,Sirinan Madnote,Hathairat Savadsuk,Jiraporn Puangkaew,Surawach Rittiroongrad,Sandhya Vasan,Viseth Ngauy,Merlin L. Robb,Jean‐Louis Excler,Punnee Pitisutthithum,Supachai Rerks‐Ngarm,Nelson L. Michael,Mark de Souza,Jérôme H. Kim,Robert J. O’Connell,Nicos Karasavvas,(unknown)	2014	3
14	Expectation of Volunteers Towards the Vaccine Efficacy of the Prime-Boost HIV Vaccine Phase III Trial During Unblinding AIDS Research and Human Retroviruses ·Kessuda Khowsroy,Jittima Dhitavat,Yupa Sabmee,Pataramon Laowarakul,Jutarat Wattanakitwichai,Jiraporn Auetian,Kannika Lothong,Roongtip Boondao,Sarawan Maythaarttaphong,Sunee Yaemwong,Jean‐Louis Excler,Supachai Rerks‐Ngarm,Punnee Pitisuttithum	2014	4
15	Immune Correlates Identified in the RV144 Vaccine Efficacy Trial Impact HIV-1 Acquisition Only in the Presence of Certain HLA Class II Genes AIDS Research and Human Retroviruses ·Heather A. Prentice,Daniel E. Geraghty,Georgia D. Tomaras,Youyi Fong,Wyatt C. Nelson,Gustavo H. Kijak,Susan Zolla‐Pazner,Sorachai Nitayaphan,Supachai Rerks‐Ngarm,Jaranit Kaewkungwal,Punnee Pitisuttithum,Nelson L. Michael,Peter B. Gilbert,Jérôme H. Kim,Rasmi Thomas	2014	0
16	Issues in Women's Participation in a Phase III Community HIV Vaccine Trial in Thailand AIDS Research and Human Retroviruses ·Jaranit Kaewkungwal,Punnee Pitisuttithum,Supachai Rerks‐Ngarm,Sorachai Nitayaphan,Chirasak Khamboonruang,Prayura Kunasol,Pravan Suntharasamai,Swangjai Pungpak,S Vanijanonta,Valai Bussaratid,Wirach Maek-a-nantawat,Jittima Dhitavat,P Thongcharoen,Rungrawee Pawarana,Yupa Sabmee,Mike W. Benenson,Patricia Morgan,Robert J. O’Connell,Jérôme H. Kim	2013	4
17	Preparing for the availability of a partially effective HIV vaccine: Some lessons from other licensed vaccines Vaccine ·Robert T. Chen,Dale J. Hu,Eileen F. Dunne,Michael W. Shaw,James I. Mullins,Supachai Rerks‐Ngarm	2011	6
18	HIV vaccines: lessons learned and the way forward Current Opinion in HIV and AIDS ·Jérôme H. Kim,Supachai Rerks‐Ngarm,Jean‐Louis Excler,Nelson L. Michael	2010	85
19	Prospective population-based incidence of Haemophilus influenzae type b meningitis in Thailand Vaccine ·Supachai Rerks‐Ngarm,Sophie Treleaven,Supamit Chunsuttiwat,Charung Muangchana,Damien Jolley,Alan D. Brooks,Surang Dejsirilert,Sirisak Warintrawat,Malcolm Guiver,Prayura Kunasol,James E. Maynard,Beverley‐Ann Biggs,Mark C. Steinhoff	2003	34
20	HIV-1 subtypes and male-to-female transmission in Thailand The Lancet ·H. M. Foy,Chaiyos Kunanusont,J Kreiss,P. Phanuphak,Suwanee Raktham,C-P. Pau,Nancy L. Young,Supachai Rerks‐Ngarm	1995	143

About Supachai Rerks‐Ngarm

Supachai Rerks‐Ngarm is a scholar working on Virology, Immunology and Infectious Diseases, having authored 43 papers that have together received 809 indexed citations. Recurring topics across this work include HIV Research and Treatment (34 papers), Immune Cell Function and Interaction (13 papers), HIV/AIDS Research and Interventions (9 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), T-cell and B-cell Immunology (8 papers), vaccines and immunoinformatics approaches (5 papers), Hepatitis B Virus Studies (4 papers) and Vaccine Coverage and Hesitancy (4 papers). The work is most often cited by research in Virology (509 citations), Infectious Diseases (291 citations) and Immunology (303 citations). Supachai Rerks‐Ngarm has collaborated with scholars based in Thailand, United States and South Korea. Frequent co-authors include Nelson L. Michael, Jérôme H. Kim, Punnee Pitisuttithum, Sorachai Nitayaphan, Jean‐Louis Excler, Jaranit Kaewkungwal, J Kreiss, Nancy L. Young, H. M. Foy and Chaiyos Kunanusont. Their work appears in journals such as The Lancet, Nature Communications and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact